Cel-Sci
CVM
$1.44
Share price
-0.69%
Change (1 day)
-34.25%
Change (1 year)
Categories
EPS for Cel-Sci (CVM)
EPS in 2023 (TTM): -$0.77
According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -$0.77. In 2022 the company made an earnings per share (EPS) of -$0.85 an increase over its 2021 EPS that were of -$0.89.
EPS history for Cel-Sci from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.77 | -9.41% |
| 2022 | -$0.85 | -4.49% |
| 2021 | -$0.89 | 3.49% |
| 2020 | -$0.86 | -2.27% |
| 2019 | -$0.88 | -33.83% |
| 2018 | -$1.33 | -51.64% |
| 2017 | -$2.75 | 23.87% |
| 2016 | -$2.22 | -70.32% |
| 2015 | -$7.48 | -39.43% |
| 2014 | -$12.35 | 49.7% |
| 2013 | -$8.25 | -46.11% |
| 2012 | -$15.31 | -43.3% |
| 2011 | -$27.00 | 35% |
| 2010 | -$20.00 | -57.89% |
| 2009 | -$47.50 | 137.5% |
| 2008 | -$20.00 | -20% |
| 2007 | -$25.00 | 0% |
| 2006 | -$25.00 | 150% |
| 2005 | -$10.00 | 0% |
| 2004 | -$10.00 | -69.23% |
| 2003 | -$32.50 | -48% |
| 2002 | -$62.50 | -53.7% |
| 2001 | -$135.00 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -1,929.26% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -1,937.66% | 🇺🇸 USA |
 Xencor XNCR | -$2.14 | 177.92% | 🇺🇸 USA |
 Curis CRIS | -$10.00 | 1,198.70% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -$2.00 | 159.74% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | -$1.25 | 62.34% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$12.08 | 1,468.83% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$5.64 | 632.47% | 🇺🇸 USA |